Ret Proto-Oncogene (RET) Peptid
RET
Wirt: Synthetic
BP, WB, IHC
-
- Target Alle Ret Proto-Oncogene (RET) Produkte
- Ret Proto-Oncogene (RET)
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Verwendungszweck
- Ret (extracellular) Negative Control Antigen
- Sequenz
- CEWRQGDGKG ITR, correspond ing to amino acid residues 541-553 of human Ret (Accession P07949).
- Produktmerkmale
- Synthetic peptide, A Blocking peptide for Anti-Ret (extracellular) Antibody (ABIN7043600, ABIN7044783 and ABIN7044784)). Intended to be used as a negative control.
- Reinheit
- >70 %
-
-
- Applikationshinweise
- Antigen Preadsorption Control: 1 μg peptide per 1 μg antibody.
- Kommentare
-
Confirmed by amino acid analysis and mass spectrometry.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- 100 μL double distilled water (DDW).
- Lagerung
- RT,-20 °C
- Informationen zur Lagerung
- Lyophilized powder can be stored intact at room temperature for two weeks. For longer periods, it should be stored at -20°C.
-
- Target
- Ret Proto-Oncogene (RET)
- Synonyme
- c-ret Peptide, cret Peptide, etID315074.13 Peptide, ret1 Peptide, wu:fd13h01 Peptide, X-ret Peptide, ret-A Peptide, xret Peptide, RET Peptide, MTC1 Peptide, CDHF12 Peptide, CDHR16 Peptide, HSCR1 Peptide, MEN2A Peptide, MEN2B Peptide, PTC Peptide, RET-ELE1 Peptide, RET51 Peptide, RET9 Peptide, c-Ret Peptide, ret proto-oncogene receptor tyrosine kinase Peptide, ret proto-oncogene S homeolog Peptide, ret proto-oncogene Peptide, ret Peptide, ret.S Peptide, RET Peptide, Ret Peptide
- Gen-ID
- 5979
- NCBI Accession
- NM_020975
- UniProt
- P07949
-
Sie sind hier:
